These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 31572393)

  • 1. The Rise of
    Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
    Front Immunol; 2019; 10():2188. PubMed ID: 31572393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine against coccidioidomycosis is justified and attainable.
    Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
    Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona.
    Kollath DR; Mihaljevic JR; Barker BM
    Microbiol Spectr; 2022 Apr; 10(2):e0148321. PubMed ID: 35319247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of innate and adaptive immunity to coccidioidomycosis.
    Hung CY; Hsu AP; Holland SM; Fierer J
    Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
    Kirkland TN; Fierer J
    Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever.
    Engelthaler DM; Roe CC; Hepp CM; Teixeira M; Driebe EM; Schupp JM; Gade L; Waddell V; Komatsu K; Arathoon E; Logemann H; Thompson GR; Chiller T; Barker B; Keim P; Litvintseva AP
    mBio; 2016 Apr; 7(2):e00550-16. PubMed ID: 27118594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity in coccidioidomycosis.
    Cox RA; Magee DM
    Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.
    Kirkland TN
    J Fungi (Basel); 2016 Dec; 2(4):. PubMed ID: 29376949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From soil to clinic: current advances in understanding
    Jackson KM; Teixeira MdM; Barker BM
    Microbiol Mol Biol Rev; 2024 Oct; ():e0016123. PubMed ID: 39365073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Response to Coccidioidomycosis and the Development of a Vaccine.
    Castro-Lopez N; Hung CY
    Microorganisms; 2017 Mar; 5(1):. PubMed ID: 28300772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.